Page 35 - Journal of Structural Heart Disease Volume 3, Issue 2

61
Case Report
Paravalvular regurgitation is expected and was ade- quately treated with vascular plugs.
Conclusion
In addition to exhibiting immediate post-interven- tional improvements and relief of symptoms without complication, both patients have remained stable in the intermediate term. One patient likely devel- oped Melody valve thrombosis, which was e ectively treated with oral anticoagulation. Pending additional long-term follow-up, these cases provide evidence of
substantial and versatile bene ts of a transcatheter approach to TV replacement, both in bioprosthetic and native TV post-surgical annuloplasty.
Con ict of Interest
The authors have no con ict of interest relevant to this publication.
Comment on this Article or Ask a Question
References
1. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: Durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674-685. DOI: 10.1016/j. jtcvs.2003.11.019
2. Jeganathan R, Armstrong S, Al-Alao B, David T. The risk and outcomes of reoper- ative tricuspid valve surgery. Ann Thorac Surg. 2013;95:119-124. DOI: 10.1016/j. athoracsur.2012.08.058
3. Marquis-Gravel G, Bouchard D, Perrault LP, Pagé P, Jeanmart H, Demers P, et al. Retro- spective cohort analysis of 926 tricuspid valve surgeries: Clinical and hemodynamic outcomes with propensity score analy- sis. Am Heart J. 2012;163:851-858. DOI: 10.1016/j.ahj.2012.02.010
4. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, et al. Comparison of the outcome of porcine bioprosthetic versus mechanical pros- thetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol. 2009;103:555-561. DOI: 10.1016/j.amj- card.2008.09.106
5. Iscan ZH, Vural KM, Bahar I, Mavioglu L, Saritas A. What to expect after tricuspid valve replacement? Long-term results. Eur J Cardiothorac Surg. 2007;32:296-300. DOI: 10.1016/j.ejcts.2007.05.003
6. McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, et al. Transcatheter tricuspid valve-in- valve implantation for the treatment of dysfunctional surgical bioprosthetic valves:
An international multicenter registry study. Circulation. 2016;133:1537-1539. DOI: 13. 10.1161/CIRCULATIONAHA.115.019353
7. Bouleti C, Himbert D, Brochet E, Ou P,
Iung B, Nejjari M, et al. Transfemoral tri- cuspid valve-in-ring implantation us-
ing the edwards sapien xt valve: One-
year follow-up. Circ Cardiovasc Interv. 14. 2015;8:e002225. DOI: 10.1161/CIRCINTER- VENTIONS.114.002225
8. Condado J, Leonardi R, Babaliaros V. Percutaneous tricuspid valve-in-ring re- placement for the treatment of recurrent severe tricuspid regurgitation. Catheter Cardiovasc Interv. 2015;86:1294-1298. DOI: 15. 10.1002/ccd.25980
9. Kefer J, Sluysmans T, Vanoverschelde JL. Transcatheter sapien valve implantation
in a native tricuspid valve after failed sur-
gical repair. Catheter Cardiovasc Interv. 2014;83:841-845. DOI: 10.1002/ccd.25330 16.
10. 10. Roberts PA, Boudjemline Y, Cheatham JP, Eicken A, Ewert P, McElhinney DB, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58:117-122. DOI: 10.1016/j.jacc.2011.01.044
11. Godart F, Baruteau AE, Petit J, Riou JY, Sassolas F, Lusson JR. Transcatheter tricuspid valve implantation: A multicenter French study. Arch Cardiovasc Dis. 2014;107:583- 591. DOI: 10.1016/j.acvd.2014.07.051
12. Dearani JA, Mora BN, Nelson TJ, Haile DT, O’Leary PW. Ebstein anomaly review: What’s now, what’s next? Expert Rev Car- diovasc Ther. 2015;13:1101-1109. DOI:
10.1586/14779072.2015.1087849
Throburn CW, Morgan JJ, Shanahan MX, Chang VP. Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. Am J Cardiol. 1983;51:1128-1132. PMID: 6837458
Egbe AC, Pislaru SV, Pellikka PA, Poteru- cha JT, Scha HV, Maleszewski JJ, et al. Bioprosthetic valve thrombosis versus structural failure: Clinical and echocar- diographic predictors. J Am Coll Car- diol. 2015;66:2285-2294. DOI: 10.1016/j. jacc.2015.09.022
Reddy YN, Connolly HM, Ammash NM. Thrombotic obstruction of a Melody valve-in-valve used for prosthetic tri- cuspid stenosis. World J Pediatr Con- genit Heart Surg. 2015;6:667-669. DOI: 10.1177/2150135115586270
Pislaur SV, Pellikka PA, Scha HV, Connolly HM. Bioprosthetic valve thrombosis: The eyes will not see what the mind does not know. J Thorac Cardiovasc Surg. 2015;149:e83-e86. DOI: 10.1016/j. jtcvs.2015.03.012
Zhou, S. et al.
Percutaneous Tricuspid Valve Replacement
Cite this article as: Zhou S, Aboulhosn J. Percutaneous Tricuspid Valve Replacement. Structural Heart Disease. 2017;3(2):55-61. DOI: http://dx.doi. org/10.12945/j.jshd.2017.012.16